Inspection Readiness for Decentralized Trials: Lessons from FDA Inspection of Pivotal DCT study Watch experts from Elligo Health Research share an overview of a study employing a DCT model, discussing the rationale behind its selection and the roles of the central Principal Investigator (PI) versus local investigators. ?? Secure your spot: https://lnkd.in/eKPrrk4n ??? Key Learning Objectives: - FDA Inspection Readiness? - How to facilitate DCTs - PI oversight of DCTs
Clinical Leader
制药业
Erie，Pennsylvania 16,568 位关注者
A resource and forum to investigate and resolve the common struggles related to running effective clinical trials.
关于我们
The landscape of the life sciences industry is as vast and varied as the professionals who work in it. Some online resources aim to serve the entire space. We wish them luck. Instead, our goal is to be the most valuable resource for a specific segment of the industry – clinical research & trials – and the professionals who make their living there. The Clinical Leader community is not made up of generalists. They’re specialists, like us. We deliver in-depth content from authoritative authors and sources because that’s what our community demands. Our editors connect with and interview top clinical executives from pharmaceutical and biotech companies who share best practices, challenges faced and overcome, clinical trends, partnering strategies, and experiences implementing new technologies. Additionally, our Clinical Leader Live series of live events provides an interactive forum where sponsor companies talk about some of today's biggest challenges when managing clinical trials. Even better, the audience gets to ask questions during the presentation.
- 网站
-
https://www.clinicalleader.com/
Clinical Leader的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Erie，Pennsylvania
- 创立
- 1995
- 领域
- Clinical Trials和CRO
动态
-
In this week's issue we'll explore: ? A Global Perspective On Paying Clinical Research Participants ? How To Structure Your Participant Payment ? Global AI In Clinical Trials: Market Trends & Current Partnerships ? How To Navigate The Complexities Of Early-Phase Ophthalmic Drug Development ? Lessons Learned From Vivani Medical's Study Of GLP-1 Implant and More! Eduardo Motti, Trials & Training | Mural Health | Mathini Ilancheran, Beroe Inc | Altasciences | Adam Mendelsohn, Vivani | IQVIA Technologies | ?Jeff De Leon MD PT | Novotech | C. Jeremy Weitz, Biogen | Ben Edwards, Avance Clinical
-
You’d be making a big mistake if you felt the SOS Save Our Sites conference was too small to attend or exhibit at. You also may be misinformed if you’ve been told this show is simply a forum for small sites to complain about being treated unfairly. After attending for the first two years, Chief Editor Dan Schell says this is one to keep on your radar. Here’s why: https://lnkd.in/e8Hi6Rgy
-
Everything from fear of loss of personal privacy to risk bias can be a concern when implementing AI in clinical trials. Elena Sinclair ?? shares her thoughts on top AI implementation concerns in this segment from a recent Clinical Leader Live: https://lnkd.in/evwCPjp9
-
-
The financial burden of clinical trial participation remains a significant barrier for many patients. To address these challenges, industry leaders are rethinking participant payment structures. Check out Mural Health's 7 key principles for participant payments: https://lnkd.in/ewR-sSfk
-
Clinical Leader Live ??? Speaker Spotlight: Karri Venn has 25 years of experience in building and running clinical research sites. Presently, she is VP Site Advocacy and Mentorship at Society for Clinical Research Sites (SCRS) and an executive consultant with a mission to support others on how to best navigate and be successful in this industry. Watch Karri and other industry experts discuss what makes a good site-sponsor partnership during our virtual event on March 27th: https://lnkd.in/eXt6VXZi Sponsored by: Medical Research Network IQVIA Technologies Advarra
-
-
Critical Imaging Risks in GLP-1 & Neurology Studies: What You Need to Know Join the webinar discussion on April 3rd to explore early indicators of imaging challenges, preclinical insights, therapeutic area trends, hidden risks in trial imaging, and more. ?? Reserve your spot for the discussion: https://lnkd.in/egaQNJcE ??? Speakers: Jessica McKenzie, Vice President, Life Sciences, 20/20 Onsite Dr. David Nguyen, MD, MBA, General Manager and Medical Director, Altasciences Dr. Simone Iwabe, DVM, PhD, DACVO, Senior Veterinary Ophthalmologist, Altasciences Dr. Colin Miller, PhD, FIPEM, CSci, Founder, Bracken
-
-
Thirty-five-year industry veteran — and also someone who's been laid off before — Larry Blankstein, Ph.D. emphasizes the importance of networking in the face of employment uncertainty. https://lnkd.in/evapiRt4
-
This webinar explores how real-time data access, self-service analytics, and traceable decisions enhance clinical trial efficiency, data quality, and patient safety. Learn how data managers and medical reviewers can collaborate effectively, use pre-built visualizations for insights, and manage queries seamlessly. A live demo will showcase tools that accelerate data understanding and streamline workflows in clinical studies. #ClinicalData #RevvitySignals #ClinicalTrial
此处无法显示此内容
在领英 APP 中访问此内容等
-
?? Webinar Tomorrow! Learn why it's critical to have a hands-on Clinical Operations lead to mitigate risks and optimize execution. ?? Secure your spot today: https://lnkd.in/eJHvuS_3 ??? Key Learning Objectives: ? Understand the critical role of sponsor-side Clinical Operations leadership in driving trial success ? Identify the risks of delegating too much responsibility to CROs and how to mitigate them ? Learn strategies for creating an effective collaboration between sponsor and outsourcing teams ? Explore real-world examples where strong Clin Ops leadership made the different in complex trials
-